Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer

7 Apr 2020

Abstract excerpt

Importance: Long noncoding RNAs (lncRNAs) are involved in innate and adaptive immunity in cancer by mediating the functional state of immunologic cells, pathways, and genes. However, whether lncRNAs are associated with immune molecular classification and clinical outcomes of cancer immunotherapy is largely unknown. Objectives: To explore lncRNA-based immune subtypes associated with survival and response to cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32259264
DOI: 10.1001/jamanetworkopen.2020.2149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With CancerPMID 32259264Read ↗

An Immune-Related lncRNA Model for Predicting Prognosis, Immune Landscape and Chemotherapeutic Response in Bladder CancerSemantic proximity Read ↗

A New Marker Constructed From Immune-related lncRNA Pairs Can be Used to Predict Clinical Treatment Effects and Prognosis: in-depth Exploration of Underlying Mechanisms in HNSCCSemantic proximity Read ↗

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancerSemantic proximity Read ↗

Immune‐related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinomaSemantic proximity Read ↗

Identification of Immune-related lncRNA Panel for Predicting Immune Checkpoint Blockade and Prognosis in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Development and verification of immune-related long non-coding RNA prognostic signature in bladder cancerSemantic proximity Read ↗

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)Semantic proximity Read ↗

Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypesSemantic proximity Read ↗

ILnc: Prioritizing Long Non-coding RNAs for Pan-cancer Analysis of Immune Cell InfiltrationSemantic proximity Read ↗

The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesSemantic proximity Read ↗

Prognostic value of immune-related lncRNA pairs in patients with bladder cancerSemantic proximity Read ↗

A Novel Signature to Predict Thyroid Cancer Prognosis and Immune Landscape Using Immune-Related LncRNA PairsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.